Two high-rated medical stocks broke out Tuesday as the sector stood out with buy opportunities.
Cynosure (CYNO) jumped 2.20 to 54.24, clearing a 53.43 buy point in 2-1/2 times its average volume. The maker of equipment for hair removal, fat loss and other cosmetic treatments reported Q2 earnings and sales that beat expectations.